Cardiovascular Disease 2009-06-14
Cardiovascular Disease – In a study of healthy volunteers, patients with cardiovascular risk factors and patients undergoing dialysis, oral intake of 2 capsules of nattokinase (2000 fibrinolysis units per capsule) daily for 2 months decreased plasma levels of fibrinogen, factor VII, and factor VIII suggesting cardiovascular risk reduction….[More]
